Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin
…, JD González, S Negri… - Blood, The Journal …, 2008 - ashpublications.org
An understanding of the prognostic factors associated with the various forms of induction
mortality in patients with acute promyelocytic leukemia (APL) has remained remarkably limited. …
mortality in patients with acute promyelocytic leukemia (APL) has remained remarkably limited. …
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome …
…, JD González, S Negri… - Blood, The Journal …, 2009 - ashpublications.org
Differentiation syndrome (DS) can be a life-threatening complication in patients with acute
promyelocytic leukemia (APL) undergoing induction therapy with all-trans retinoic acid (ATRA)…
promyelocytic leukemia (APL) undergoing induction therapy with all-trans retinoic acid (ATRA)…
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results
…, J Bergua, T Lamy, A Vekhoff, S Negri… - Blood, The Journal …, 2008 - ashpublications.org
All-trans retinoic acid (ATRA) plus anthracycline chemotherapy is the reference treatment of
newly diagnosed acute promyelocytic leukemia (APL), whereas the role of cytosine …
newly diagnosed acute promyelocytic leukemia (APL), whereas the role of cytosine …
Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives
…, E Zinellu, P Pirina, S Negri… - European …, 2018 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised
by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a …
by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a …
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 …
…, R Parody, JM Bergua, A León, S Negri… - Blood, The Journal …, 2008 - ashpublications.org
A previous report of the Programa de Estudio y Tratamiento de las Hemopatías Malignas (PETHEMA)
Group showed that a risk-adapted strategy combining all-trans retinoic acid (ATRA…
Group showed that a risk-adapted strategy combining all-trans retinoic acid (ATRA…
[HTML][HTML] Blood cell count derived inflammation indexes in patients with idiopathic pulmonary fibrosis
…, E Sotgiu, S Mellino, AA Mangoni, E Zinellu, S Negri… - Lung, 2020 - Springer
Purpose Inflammation and immunity play a pivotal but yet unclear role in idiopathic
pulmonary fibrosis (IPF), a chronic disorder characterized by progressive damage of lung …
pulmonary fibrosis (IPF), a chronic disorder characterized by progressive damage of lung …
[HTML][HTML] Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline …
…, C Rivas, M González, JD González, S Negri… - …, 2009 - ncbi.nlm.nih.gov
… González, 17 Silvia Negri, 18 Salut Brunet, 19 Bob Lowenberg, 20 and Miguel A. Sanz 1 …
Negri; Instituto Privado de Hematología, Paraná; Instituto de Trasplante de Médula Ósea …
Negri; Instituto Privado de Hematología, Paraná; Instituto de Trasplante de Médula Ósea …
[HTML][HTML] Effects of pirfenidone and nintedanib on markers of systemic oxidative stress and inflammation in patients with idiopathic pulmonary fibrosis: a preliminary …
AG Fois, E Sotgiu, V Scano, S Negri, S Mellino… - Antioxidants, 2020 - mdpi.com
Introduction: In vitro evidence suggests that pirfenidone and nintedanib, approved agents
for the treatment of idiopathic pulmonary fibrosis (IPF), exert anti-inflammatory and anti-oxidant …
for the treatment of idiopathic pulmonary fibrosis (IPF), exert anti-inflammatory and anti-oxidant …
Association between routine blood biomarkers and clinical phenotypes and exacerbations in chronic obstructive pulmonary disease
Introduction Chronic obstructive pulmonary disease (COPD) is associated with increased
lung and systemic inflammation. We aimed to identify associations between easy-to-obtain …
lung and systemic inflammation. We aimed to identify associations between easy-to-obtain …
Point-of-care testing for HCV infection: recent advances and implications for alternative screening.
…, C Mabellini, T Belloni, L Brignolo, S Negri… - The New …, 2014 - europepmc.org
Over the last few years, hepatitis C virus (HCV) infection has emerged as one of the most
significant causes of chronic liver disease worldwide, with an estimated prevalence ranging …
significant causes of chronic liver disease worldwide, with an estimated prevalence ranging …